Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Article Title: Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
doi: 10.1200/JCO.2017.74.0472
Figure Lengend Snippet: Summary of Original Recommendations for Question 1 With Focused Updated Recommendations
Article Snippet: 1.6 , If a patient has HER2-positive breast cancer or triple-negative breast cancer, the clinician should not use 12-gene risk score (EndoPredict; Sividon Diagnostics) to guide decisions for adjuvant systemic therapy. , Type: informal consensus Evidence quality: insufficient Strength of recommendation: strong.
Techniques: Adjuvant, Labeling, Immunohistochemistry, Gene Expression